Peptides and metabolic therapies
A lecture series on peptide and metabolic therapies: the hormone axes they act on, incretin drugs for weight loss, repair peptides such as BPC-157 and TB-500, NAD+ and mitochondrial compounds, and what the evidence does and doesn’t support.
Many of the compounds covered here are not FDA-approved for these uses, and some are sold only as research chemicals. These videos review the evidence, including where it is only preclinical. They are not a recommendation to use any of them.

01The GH–IGF-1 axis
- 01The GH–IGF-1 axis
- 02GLP-1/GIP dual agonists
- 03GLP-1/GIP/glucagon agonists
- 04Novel fat-loss compounds
- 05BPC-157
- 06TB-500 and the thymosins
- 07KPV and the melanocortin peptides
- 08GHK-Cu and copper peptides
- 09NAD+ and its precursors
- 10Mitochondrial compounds
- 11Blended peptides: GLOW and KLOW
- 12The HPG axis: LH, FSH and testosterone
- 13Semax, Selank and Cerebrolysin
- 14PT-141 (bremelanotide)
These videos are for general education and are not medical advice for any individual. Disclosures